Clinical Trials Logo

Clinical Trial Summary

Generally, a contrast medium is used when performing a CT scan or radiographic tests such as angiography because it heightens image clarity and can increase diagnosis accuracy. Despite these advantages, contrast media can cause allergic reactions in the body or a decline in renal function. Therefore, they should be handled carefully and explained sufficiently to the patient. For intensive care patients, the use of contrast agents has been revealed as a major cause of acute renal damage, and many studies have investigated this complication by examining incidence rates and prevention strategies. Hypothesis: Among intensive care patients, the group in which a contrast medium was used will have a higher risk of renal function decline compared with the group in which a contrast medium was not used, and, hence, the use of contrast media becomes a cause of renal function deterioration. Categorizing patients with renal function decline according to the new RIFLE criteria can have an association with the prognosis of intensive care patients, such as hospitalization period and death rate, which can promote faster intervention.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01807195
Study type Observational
Source Yonsei University
Contact
Status Completed
Phase N/A
Start date February 2013
Completion date February 2014

See also
  Status Clinical Trial Phase
Completed NCT01920542 - Dexmedetomidine on Pediatric Heart Operation N/A
Recruiting NCT04334707 - Kidney Precision Medicine Project
Completed NCT02765464 - Acute Kidney Injury in Critically Ill Patients
Recruiting NCT05970952 - Acute Kidney Injury in Intensive Care Patients
Recruiting NCT05145283 - Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation Phase 2
Active, not recruiting NCT05384899 - Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Completed NCT04600271 - Acute Renal Injury After Major Elective Non-Cardiac Surgery
Completed NCT02838667 - Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI) N/A
Not yet recruiting NCT05666232 - Renal and Cardiac Risk Factors of AKI After Liver Transplantation
Completed NCT02974946 - Kidney Protection Using the RenalGuard® System in Cardiac Surgery N/A
Recruiting NCT05186636 - Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans
Not yet recruiting NCT05308810 - Postoperative Kidney Functions in Geriatric Major Gynecologic-Oncologic Surgery
Recruiting NCT02743156 - Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy Phase 4
Recruiting NCT02417896 - Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery N/A